Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Myslivecek

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Vnitrni Lekarstvi|January 25, 2002
[Prognostic significance of stress tomographic scintigraphy of myocardial perfusion in diabetic patients]M Kamínek, M Myslivecek, M Skvarilová, et al.
Neoplasma|April 29, 2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CTT Papajik, M Myslivecek, M Skopalova, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Neoplasma|March 20, 2008
High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionT Papajik, L Raida, E Faber, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Vnitrni Lekarstvi|January 25, 2002
[Prognostic significance of stress tomographic scintigraphy of myocardial perfusion in diabetic patients]M Kamínek, M Myslivecek, M Skvarilová, et al.
Neoplasma|April 29, 2011
Determining the extent and stage of disease in patients with newly diagnosed non-Hodgkin's lymphoma using 18F-FDG-PET/CTT Papajik, M Myslivecek, M Skopalova, et al.
Journal of Nephrology|December 31, 2020
Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injuryN Steiner, A Abdel Hamid, A Kronbichler, et al.
Neoplasma|March 20, 2008
High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remissionT Papajik, L Raida, E Faber, et al.
Pageof 3